Home Medicare Part D Tags

View the Latest: Medicare Part D

Filter

List Grid

31 - 40 of 467 Results

  • Health News Index – September/October 2000

    Poll Finding

    Health News Index September/October, 2000 The September/October 2000 edition of the Kaiser Family Foundation/HarvardSchool of Public Health, Health News Index includes questions about how closely the public is following and how well they understand major health stories covered in the news during September, including stories about presidential candidates Al Gore and George W. Bush's prescription drug proposals. Every two months, Kaiser/Harvard issues a new index report. HNI September-October 2000 Topline/Survey MEDIA ADVISORY Download

  • Kaiser Health Poll Report Survey: Seniors’ Early Experiences with the Medicare Prescription Drug Benefit

    Poll Finding

    Kaiser Health Poll Report Survey: Seniors' Early Experiences with the Medicare Prescription Drug Benefit This April 2006 tracking poll finds that most seniors enrolled in a Medicare drug plan are satisfied with their plan and are not having trouble getting the drugs they need. Most seniors enrolled in plans reported filling at least one prescription, and the vast majority of them -- more than 8 in 10 -- reported no problems getting their prescriptions filled.…

  • Medicare Part D: A First Look at Medicare Prescription Drug Plans in 2022

    Issue Brief

    This issue brief provides an overview of the Medicare Part D prescription drug benefit market for 2022, with a primary focus on stand-alone drug plans. It includes national and state-level data on plan availability, premiums, benefit design, cost sharing, information about premium-free plans for low-income beneficiaries, and information about the national Part D drug plans available in 2022.

  • Medicare Chartbook

    Report

    The Medicare Chartbook includes data and background information critical to understanding the Medicare program and the challenges it faces in keeping up with the rising costs of health care and in ensuring the program s future financial security.

  • Grievance and Appeals Procedures: An Analysis of the MMA and Proposed Regulations

    Issue Brief

    This paper, by Sara Rosenbaum, J.D., Director of the Center for Health Services Research and Policy at George Washington University, examines the procedures for resolving beneficiaries' grievances and appeals under the new Medicare drug benefit. It is one in a series commissioned by the Kaiser Family Foundation that analyzes issues surrounding the implementation of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) and the proposed regulations. Issue Brief (.pdf)

  • National Survey of Pharmacists 2006: Full Topline Results

    Poll Finding

    National Survey of Pharmacists 2006: Full Topline Results These toplines provide additional findings from a 2006 national survey of pharmacists on their views and experiences on a wide range of health care issues. Toplines (.pdf)

  • Health Care Agenda for the New Congress – Toplines

    Poll Finding

    This document includes the complete toplines from a survey of the public's attitudes regarding the health care agenda for Bush's second term and the new Congress in 2005. It assesses the relative priority placed on health-care concerns by the American public and also provides insight into public opinion on key issues likely to face the new Congress, such as implementing the Medicare drug law, controlling health care costs, reducing the nation’s uninsured population and reforming…

  • New Survey Assesses Senior’s Views of Medicare Drug Law

    Poll Finding

    New Survey Assesses Senior's Views of Medicare Drug Law Seniors are most likely to say they would turn to their doctor, pharmacist, or the Medicare program, for help in making decisions about the new Medicare drug benefit set to begin Jan. 1, 2006, according to new data from the Kaiser Health Poll Report tracking survey. The tracking survey also provides updated tracking data on seniors’ knowledge and views of the new Medicare law. Foundation President…

  • Targeting Medicare Drug Benefits: Costs and Issues

    Report

    This report, written by Marilyn Moon and Matthew Storeygard of the Urban Institute, estimates the potential cost of targeting drug benefits to low-income Medicare beneficiaries and those with catastrophic drug expenses and discusses some of the key programmatic issues that could arise under this approach. The authors predict that a targeted and comprehensive drug benefit would likely help more than half of the 11.3 million low-income beneficiaries who lack drug coverage through Medicaid or an…